Yury V. Ovchinnikov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yury V. Ovchinnikov has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Nikolay Ivanovich Gulyaev
National Medical Research Center for High Medical Technologies — A. A. Vishnevsky Central Military Clinical Hospital; Branch of the Kirov Military Medical Academy; Peoples’ Friendship University of Russia
3 shared publications - Zulfiya N. Sukmarova
Nasonova Research Institute of Rheumatology
3 shared publications - M. V. Emelianenko
Clinical City Hospital named after M.P. Konchalovsky
2 shared publications - Marina V. Palchenkova
Military Medical Academy
2 shared publications - Maxim A. Lebedev
Military Medical Academy
2 shared publications - Mikhail B. Patsenko
Military Medical Academy
2 shared publications
Latest Publications
- 14 February 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 103 (10-11)
Hypertrophic apical cardiomyopathy (Yamaguchi syndrome): decision-making tactics
The article describes apical hypertrophic cardiopathy, its etiology and pathogenesis. A clinical case of a patient with apical hypertrophic cardiomyopathy is presented. The features of the course of the disease, modern approaches to assessing the prognosis are described. The issues of differential diagnosis are considered.
- 14 February 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 103 (10-11)
Hypertrophic apical cardiomyopathy (Yamaguchi syndrome): decision-making tactics
The article describes apical hypertrophic cardiopathy, its etiology and pathogenesis. A clinical case of a patient with apical hypertrophic cardiomyopathy is presented. The features of the course of the disease, modern approaches to assessing the prognosis are described. The issues of differential diagnosis are considered.
- Open Access
- 31 July 2024
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 43 (2) , 141-150
Diagnosis of hemostatic system disorders in patients with chronic heart failure using classical and integral methods
BACKGROUND: The state of the hemostatic system in patients with chronic heart failure (CHF) remains an insufficiently studied problem. PURPOSE OF THE STUDY: to present the results of an original study of the coagulation system of patients with CHF using an integral technique — low-frequency piеzothromboelastography (LPTEG). MATERIAL AND METHODS: The study involved 90 patients with CHF due to hypertension and coronary artery disease aged 50–75 years. The subjects were divided into groups with CHF I–IIa (n = 30), CHF stages IIb–III (n = 60). All patients underwent a study of the hemostasis system using classical (coagulogram) and integral (NPTEG) methods before prescribing antiplatelet and anticoagulant therapy. The comparison group consisted of healthy patients of the same age group without CHF (n = 30). RESULTS: In patients with CHF, a general blood test revealed a statistically significant decrease in the number of platelets (group 1 — 215; group 2 — 185) compared to the control group — 241. When analyzing the coagulogram, a decrease in the levels of prothrombin (group 1 — 89; group 2 — 86; control group 105), antithrombin-III (group — 76.5; group 2 — 73; control group — 91) and increased INR (group 1 — 1.03; group 2 — 1.12; control group 1.01) in patients in groups with CHF compared to the control group (p 0.05). When using the NPTEG method in patients with CHF, a decrease in indicators characterizing the rate of clot polymerization (intensity of clot polymerization) and clot density (maximum amplitude) was determined when compared with the control group (p 0.05). CONCLUSION: In patients with CHF, changes in the hemostatic system are determined, characterized by a tendency to hypocoagulation, the frequency a severity of which increases with the progression of the stage of the disease.
- 31 July 2024
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 43 (2) , 141-150
Open AccessDiagnosis of hemostatic system disorders in patients with chronic heart failure using classical and integral methods
BACKGROUND: The state of the hemostatic system in patients with chronic heart failure (CHF) remains an insufficiently studied problem. PURPOSE OF THE STUDY: to present the results of an original study of the coagulation system of patients with CHF using an integral technique — low-frequency piеzothromboelastography (LPTEG). MATERIAL AND METHODS: The study involved 90 patients with CHF due to hypertension and coronary artery disease aged 50–75 years. The subjects were divided into groups with CHF I–IIa (n = 30), CHF stages IIb–III (n = 60). All patients underwent a study of the hemostasis system using classical (coagulogram) and integral (NPTEG) methods before prescribing antiplatelet and anticoagulant therapy. The comparison group consisted of healthy patients of the same age group without CHF (n = 30). RESULTS: In patients with CHF, a general blood test revealed a statistically significant decrease in the number of platelets (group 1 — 215; group 2 — 185) compared to the control group — 241. When analyzing the coagulogram, a decrease in the levels of prothrombin (group 1 — 89; group 2 — 86; control group 105), antithrombin-III (group — 76.5; group 2 — 73; control group — 91) and increased INR (group 1 — 1.03; group 2 — 1.12; control group 1.01) in patients in groups with CHF compared to the control group (p 0.05). When using the NPTEG method in patients with CHF, a decrease in indicators characterizing the rate of clot polymerization (intensity of clot polymerization) and clot density (maximum amplitude) was determined when compared with the control group (p 0.05). CONCLUSION: In patients with CHF, changes in the hemostatic system are determined, characterized by a tendency to hypocoagulation, the frequency a severity of which increases with the progression of the stage of the disease.
- 24 July 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (4) , 331-337
A decrease in the concentration of free blood glutathione in the acute phase of coronavirus infection
Aim of the study: to investigate the dynamics of glutathione metabolite concentrations in the blood of patients during the acute phase of coronavirus infection, as well as their dependencies on each other, on NAD⁺ metabolites, the severity of the infl ammatory response, and pre-existing conditions. Materials and methods. Changes in the concentration of oxidized and reduced forms of glutathione and their ratio, as well as clinical and biochemical parameters, including NAD⁺ and NADPH⁺ metabolites, were analyzed in patients with new coronavirus infection COVID-19 during the acute phase. Results. A signifi cant decrease in the concentration of both reduced and oxidized forms of glutathione and an increase in the ratio of reduced to oxidized forms compared to the control were demonstrated. A positive correlation was noted between the severity of respiratory failure and the oxidized form of glutathione and NADPH⁺. The reduced form of glutathione had a positive correlation with the concentration of NAD⁺ and NADPH⁺ and a negative correlation with the presence of obesity and ferritin concentration. Conclusion. For the fi rst time, a decrease in the concentration of key components of the cell’s antioxidant defense system — glutathione system — has been shown in patients with COVID-19, opening up prospects for the development of treatment methods for patients in the active phase using sulfhydryl group donors.
- 24 July 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (4) , 331-337
A decrease in the concentration of free blood glutathione in the acute phase of coronavirus infection
Aim of the study: to investigate the dynamics of glutathione metabolite concentrations in the blood of patients during the acute phase of coronavirus infection, as well as their dependencies on each other, on NAD⁺ metabolites, the severity of the infl ammatory response, and pre-existing conditions. Materials and methods. Changes in the concentration of oxidized and reduced forms of glutathione and their ratio, as well as clinical and biochemical parameters, including NAD⁺ and NADPH⁺ metabolites, were analyzed in patients with new coronavirus infection COVID-19 during the acute phase. Results. A signifi cant decrease in the concentration of both reduced and oxidized forms of glutathione and an increase in the ratio of reduced to oxidized forms compared to the control were demonstrated. A positive correlation was noted between the severity of respiratory failure and the oxidized form of glutathione and NADPH⁺. The reduced form of glutathione had a positive correlation with the concentration of NAD⁺ and NADPH⁺ and a negative correlation with the presence of obesity and ferritin concentration. Conclusion. For the fi rst time, a decrease in the concentration of key components of the cell’s antioxidant defense system — glutathione system — has been shown in patients with COVID-19, opening up prospects for the development of treatment methods for patients in the active phase using sulfhydryl group donors.
- Open Access
- 31 May 2023
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 101 (4-5) , 181-187
Changes in the blood coagulation system in patients with chronic heart failure
The article provides a review of scientifi c publications dedicated to the study of the hemostatic system in patients with chronic heart failure (CHF). Russian and foreign authors evaluated the risks of bleeding and thrombosis in patients with CHF, as well as changes in the content of individual markers and factors of the coagulation system. The review suggests that the results obtained are quite contradictory. On the one hand, data is presented on an increased risk of thrombosis, changes in the content of some endothelial markers that promote endothelial thrombogenicity, an increase in the content of platelet aggregation markers, and elevated levels of fi brinogen and thrombin. On the other hand, there is data on an increased risk of bleeding in patients with CHF, an increase in some endothelial markers that enhance the anticoagulant properties of the endothelium. From the analysis conducted, it can be concluded that this topic is not suffi ciently studied, and it is diffi cult to judge the hemostatic potential in patients with CHF at present. The use of integrated methods such as thromboelastography (TEG) and low-frequency piezothromboelastography (LF-PTEG) are a promising direction for studying this problem. The results obtained using these methods will likely allow for a more precise understanding of the features of the coagulation system functioning in patients with CHF.
- 31 May 2023
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 101 (4-5) , 181-187
Open AccessChanges in the blood coagulation system in patients with chronic heart failure
The article provides a review of scientifi c publications dedicated to the study of the hemostatic system in patients with chronic heart failure (CHF). Russian and foreign authors evaluated the risks of bleeding and thrombosis in patients with CHF, as well as changes in the content of individual markers and factors of the coagulation system. The review suggests that the results obtained are quite contradictory. On the one hand, data is presented on an increased risk of thrombosis, changes in the content of some endothelial markers that promote endothelial thrombogenicity, an increase in the content of platelet aggregation markers, and elevated levels of fi brinogen and thrombin. On the other hand, there is data on an increased risk of bleeding in patients with CHF, an increase in some endothelial markers that enhance the anticoagulant properties of the endothelium. From the analysis conducted, it can be concluded that this topic is not suffi ciently studied, and it is diffi cult to judge the hemostatic potential in patients with CHF at present. The use of integrated methods such as thromboelastography (TEG) and low-frequency piezothromboelastography (LF-PTEG) are a promising direction for studying this problem. The results obtained using these methods will likely allow for a more precise understanding of the features of the coagulation system functioning in patients with CHF.
- Open Access
- 6 January 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (2) , 3405
Mitral valve chordal rupture against the background of cardiac SARS-CoV-2 infection. Cases series
In an ever-changing information flow on coronavirus disease 2019 (COVID-19) pandemic, we describe a case series of mitral valve chordal rupture (MVCR) in non-comorbid middle-aged men that occurred over a period of 3 to 5 weeks after Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection. With significant advances in the prevention of acute rheumatic fever, the treatment of bacterial endocarditis and acute coronary syndrome, acute mitral regurgitation has become a relatively rare diagnosis. During the pandemic, there has been a surge in the incidence of spontaneous MVCR, and new data on the problem are accumulating. The presented case series are united by the fact that the infection symptoms were mild, followed by signs of probable endomyocarditis, unrecognized in time, and acute mitral valve regurgitation developed against the background of physical provocation (exercise and cough). Two patients had previously been diagnosed with mitral valve prolapse (myxomatous degeneration and connective tissue disease). Two patients were successfully operated on in different clinics. The described cases emphasize that the consequences of inflammation persistence may be more severe than the primary viral damage, which determines the importance of a comprehensive examination and long-term follow-up. To date, the differential diagnosis of patients with sudden onset of dyspnea and chest pain associated with an infectious process should include MVCR.
- 6 January 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (2) , 3405
Open AccessMitral valve chordal rupture against the background of cardiac SARS-CoV-2 infection. Cases series
In an ever-changing information flow on coronavirus disease 2019 (COVID-19) pandemic, we describe a case series of mitral valve chordal rupture (MVCR) in non-comorbid middle-aged men that occurred over a period of 3 to 5 weeks after Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection. With significant advances in the prevention of acute rheumatic fever, the treatment of bacterial endocarditis and acute coronary syndrome, acute mitral regurgitation has become a relatively rare diagnosis. During the pandemic, there has been a surge in the incidence of spontaneous MVCR, and new data on the problem are accumulating. The presented case series are united by the fact that the infection symptoms were mild, followed by signs of probable endomyocarditis, unrecognized in time, and acute mitral valve regurgitation developed against the background of physical provocation (exercise and cough). Two patients had previously been diagnosed with mitral valve prolapse (myxomatous degeneration and connective tissue disease). Two patients were successfully operated on in different clinics. The described cases emphasize that the consequences of inflammation persistence may be more severe than the primary viral damage, which determines the importance of a comprehensive examination and long-term follow-up. To date, the differential diagnosis of patients with sudden onset of dyspnea and chest pain associated with an infectious process should include MVCR.
- Open Access
- 30 April 2022
- Published by National Alliance of Medicine and Sports - Healthy Generation in Sports medicine: research and practice
- Vol. 12 (1) , 77-85
Acute mitral chodae rupture in the early postcovid in heavy physical active men. Case series
The opinion that COVID-19 is a greater threat only to the elderly people has changed over the past year. Experience has been accumulated in the development of complications of varying severity in young patients who had optimal health indicators before infection. The consequences of myocarditis are most dangerous, especially in athletes and military personnel. We present a series of clinical cases of spontaneous mitral valve chordae rupture in highly trained middle-aged men in the early post-COVID period. In all cases, the infection proceeded subclinically; SARS-CoV-2 was verified only by analysis for IgM. 1–2 weeks after infection, against the background of a routine training process, patients felt pain in the heart area, which was underestimated. Patients presented for help at 2 and 10 weeks with complaints of reduced endurance and shortness of breath. Echocardiography revealed rupture of one of the chords of the anterior part of the mitral valve against the background of signs of myocarditis with the development of valvular insufficiency of the 1st degree. By the time of treatment, the pathology of other laboratory data and ECG was not observed. The control after 6 months showed in 1 patient a focus of myocardial fibrosis according to MRI, a minimal increase in NT-proBNP, a decrease in exercise tolerance, in 2 patients there was no visible fibrosis, normal NT-proBNP and complete restoration of exercise tolerance, but a decrease in local myocardial deformation according to echocardiography.
- 30 April 2022
- Published by National Alliance of Medicine and Sports - Healthy Generation in Sports medicine: research and practice
- Vol. 12 (1) , 77-85
Open AccessAcute mitral chodae rupture in the early postcovid in heavy physical active men. Case series
The opinion that COVID-19 is a greater threat only to the elderly people has changed over the past year. Experience has been accumulated in the development of complications of varying severity in young patients who had optimal health indicators before infection. The consequences of myocarditis are most dangerous, especially in athletes and military personnel. We present a series of clinical cases of spontaneous mitral valve chordae rupture in highly trained middle-aged men in the early post-COVID period. In all cases, the infection proceeded subclinically; SARS-CoV-2 was verified only by analysis for IgM. 1–2 weeks after infection, against the background of a routine training process, patients felt pain in the heart area, which was underestimated. Patients presented for help at 2 and 10 weeks with complaints of reduced endurance and shortness of breath. Echocardiography revealed rupture of one of the chords of the anterior part of the mitral valve against the background of signs of myocarditis with the development of valvular insufficiency of the 1st degree. By the time of treatment, the pathology of other laboratory data and ECG was not observed. The control after 6 months showed in 1 patient a focus of myocardial fibrosis according to MRI, a minimal increase in NT-proBNP, a decrease in exercise tolerance, in 2 patients there was no visible fibrosis, normal NT-proBNP and complete restoration of exercise tolerance, but a decrease in local myocardial deformation according to echocardiography.
- Open Access
- 17 November 2021
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (2) , 3021
Effusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series
A wide variety of non-pulmonary manifestations of a coronavirus disease 2019 (COVID-19) has enriched clinical performance of cardiac diseases with atypical symptoms. Two COVID-19 cases are presented, where sinus bradycardia and syncope, which are rare in COVID-19, were the leading ones after the infection. The patients had no prior cardiovascular diseases, while the examination did not detected neurological pathology and myocarditis. Echocardiography showed relatively small pericardial effusion, which is supposed to be a cause of the symptoms as the diagnosis to exclude. A local buildup of inflammatory fluid around the sinus node and extensive ganglion plexuses around the atria can possibly affect the automatism and chronotropic compensation in addition to the myocardial inflammation. As part of the treatment against the hydropericardium syndrome, the symptoms disappeared, without reoccurring within subsequent 6-month follow-up. The third clinical case regards the pandemic outbreak, when we could not even suspect that the systemic inflammation would persist for many months after COVID-19 and radiofrequency ablation can lead to sudden cardiac death.
- 17 November 2021
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (2) , 3021
Open AccessEffusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series
A wide variety of non-pulmonary manifestations of a coronavirus disease 2019 (COVID-19) has enriched clinical performance of cardiac diseases with atypical symptoms. Two COVID-19 cases are presented, where sinus bradycardia and syncope, which are rare in COVID-19, were the leading ones after the infection. The patients had no prior cardiovascular diseases, while the examination did not detected neurological pathology and myocarditis. Echocardiography showed relatively small pericardial effusion, which is supposed to be a cause of the symptoms as the diagnosis to exclude. A local buildup of inflammatory fluid around the sinus node and extensive ganglion plexuses around the atria can possibly affect the automatism and chronotropic compensation in addition to the myocardial inflammation. As part of the treatment against the hydropericardium syndrome, the symptoms disappeared, without reoccurring within subsequent 6-month follow-up. The third clinical case regards the pandemic outbreak, when we could not even suspect that the systemic inflammation would persist for many months after COVID-19 and radiofrequency ablation can lead to sudden cardiac death.
- Open Access
- 15 August 2021
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 93 (8) , 923-931
Gastroenterological symptoms in COVID-19 patients with mild severity of the disease: opportunities to optimize antidiarrheal therapy
Background. The novel coronavirus infection COVID-19 can be manifested by damage to the organs of the gastrointestinal tract (GIT). Damage to the gastrointestinal tract by the SARS-CoV-2 virus leads to a violation of the microbial-tissue complex of the mucous membrane of the digestive tract. A common gastroenterological manifestation of COVID-19 is diarrhea. Aim. Study of the clinical features of gastroenterological disorders and the possibility of optimizing the treatment of diarrheal syndrome in patients with COVID-19 with a mild form of viral infection. Materials and methods. The observation group consisted of 230 patients with mild COVID-19: K-group (n=115) with respiratory symptoms, I group (n=115) with gastrointestinal manifestations in combination and without signs of respiratory damage. In order to compare the effectiveness of treatment of diarrheal syndrome, patients of group I are randomized into 2 subgroups: Ia (n=58) prebiotic treatment (Zacofalk) and Ib (n=57) enterosorbents. Results. The development of gastrointestinal symptoms with SARS-CoV-2 infection is significantly more often noted in comorbid patients (67%). Gastrointestinal symptoms were dominated by diarrhea (93.9%) and flatulence (76.5%), in 1/3 of patients they were the first manifestos of infection. It was established that in 98.4% of patients of group I (against 42.6% of the K-group) signs of infectious intoxication were detected. In patients with gastrointestinal lesions, an elongation of the febrile period by 91.5 days was noted, a later (6 days) verification of the viral etiology of the disease. It was found that in patients of group I, the regression of clinical symptoms, the duration of viral disease, the dynamics of antibody formation, the prognosis for the development of IBS-like disorders in the post-infectious period depended on the treatment. In patients taking (Zacofalk), these indicators were significantly better. Conclusion. In mild cases, to reduce the severity of viral intestinal damage, for effective relief of intestinal symptoms, to reduce the risk of IBS-like symptoms, it is advisable to prescribe (Zacofalk) in an initial dose of 3 tablets per day.
- 15 August 2021
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 93 (8) , 923-931
Open AccessGastroenterological symptoms in COVID-19 patients with mild severity of the disease: opportunities to optimize antidiarrheal therapy
Background. The novel coronavirus infection COVID-19 can be manifested by damage to the organs of the gastrointestinal tract (GIT). Damage to the gastrointestinal tract by the SARS-CoV-2 virus leads to a violation of the microbial-tissue complex of the mucous membrane of the digestive tract. A common gastroenterological manifestation of COVID-19 is diarrhea. Aim. Study of the clinical features of gastroenterological disorders and the possibility of optimizing the treatment of diarrheal syndrome in patients with COVID-19 with a mild form of viral infection. Materials and methods. The observation group consisted of 230 patients with mild COVID-19: K-group (n=115) with respiratory symptoms, I group (n=115) with gastrointestinal manifestations in combination and without signs of respiratory damage. In order to compare the effectiveness of treatment of diarrheal syndrome, patients of group I are randomized into 2 subgroups: Ia (n=58) prebiotic treatment (Zacofalk) and Ib (n=57) enterosorbents. Results. The development of gastrointestinal symptoms with SARS-CoV-2 infection is significantly more often noted in comorbid patients (67%). Gastrointestinal symptoms were dominated by diarrhea (93.9%) and flatulence (76.5%), in 1/3 of patients they were the first manifestos of infection. It was established that in 98.4% of patients of group I (against 42.6% of the K-group) signs of infectious intoxication were detected. In patients with gastrointestinal lesions, an elongation of the febrile period by 91.5 days was noted, a later (6 days) verification of the viral etiology of the disease. It was found that in patients of group I, the regression of clinical symptoms, the duration of viral disease, the dynamics of antibody formation, the prognosis for the development of IBS-like disorders in the post-infectious period depended on the treatment. In patients taking (Zacofalk), these indicators were significantly better. Conclusion. In mild cases, to reduce the severity of viral intestinal damage, for effective relief of intestinal symptoms, to reduce the risk of IBS-like symptoms, it is advisable to prescribe (Zacofalk) in an initial dose of 3 tablets per day.
- 4 June 2021
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 99 (1) , 6-14
Present aspects of thrombolytic therapy of pulmonary artery thromboembolism
The concept of high-risk pulmonary artery embolism determines that verification of the occlusion of the pulmonary arterial bed requires urgent restoration of pulmonary blood flow in such patients. Thrombolytic therapy is currently recognized as the main treatment for pulmonary artery thromboembolism. It can save patients’ lives, prevent the development of chronic post embolic pulmonary hypertension and thromboembolism recurrence. The literature review presents thrombolytic medications used in the treatment of pulmonary thromboembolism, describes indications for thrombolytic therapy, comparative efficiency and safety of various thrombolytics. The main complications of thrombolytic therapy are described and the issues of increasing its safety are raised. Criteria for the success of thrombolysis are early diagnosis, accurate risk stratification, and adequate use of reperfusion agents in patients with high-risk or transitionally high-risk of pulmonary embolism.
- 4 June 2021
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 99 (1) , 6-14
Present aspects of thrombolytic therapy of pulmonary artery thromboembolism
The concept of high-risk pulmonary artery embolism determines that verification of the occlusion of the pulmonary arterial bed requires urgent restoration of pulmonary blood flow in such patients. Thrombolytic therapy is currently recognized as the main treatment for pulmonary artery thromboembolism. It can save patients’ lives, prevent the development of chronic post embolic pulmonary hypertension and thromboembolism recurrence. The literature review presents thrombolytic medications used in the treatment of pulmonary thromboembolism, describes indications for thrombolytic therapy, comparative efficiency and safety of various thrombolytics. The main complications of thrombolytic therapy are described and the issues of increasing its safety are raised. Criteria for the success of thrombolysis are early diagnosis, accurate risk stratification, and adequate use of reperfusion agents in patients with high-risk or transitionally high-risk of pulmonary embolism.
- 28 March 2021
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 98 (9-10) , 685-690
Mathematical model for forecasting postablative atrial fibrillation in patients with typical atrial flutter
The article represents clinical, instrumental and electrophysiological predictors of postablative atrial fi brillation (AF) occurrence after radiofrequency ablation of cavotricuspid isthmus in 209 patients with typical atrial fl utter. The results of our own experience in the treatment of these patients are analyzed. The technique of the modifi ed intraoperative electrophysiological test of AF induction in patients with typical atrial fl utter is described. The role of this technique in the occurrence of postablative AF is evaluated. A mathematical model for predicting postablative AF at the intraoperative stage of treatment of patients with typical atrial fl utter has been developed.
- 28 March 2021
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 98 (9-10) , 685-690
Mathematical model for forecasting postablative atrial fibrillation in patients with typical atrial flutter
The article represents clinical, instrumental and electrophysiological predictors of postablative atrial fi brillation (AF) occurrence after radiofrequency ablation of cavotricuspid isthmus in 209 patients with typical atrial fl utter. The results of our own experience in the treatment of these patients are analyzed. The technique of the modifi ed intraoperative electrophysiological test of AF induction in patients with typical atrial fl utter is described. The role of this technique in the occurrence of postablative AF is evaluated. A mathematical model for predicting postablative AF at the intraoperative stage of treatment of patients with typical atrial fl utter has been developed.